Companies / France
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Sanofi-Aventis Seeks To Acquire Biotech Player
December 2006 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Following a year of furious M&A activity, France's Sanofi-Aventis has revealed that it is interested buying a biotechnology firm with "three or four products" that is in the mould of US-based stellar performer Genentech. Biotech is currently outperforming the traditional small-molecule industry and Sanofi-Aventis is hoping to get its share of the action as it faces falling revenue from patent expiries and state-imposed cost-containment measures. BMI concurs with the French firm's rationale but is highly sceptical that it will secure a company of Genentech's